Bioactive Compounds
-
B2297 GW4417561 CitationTarget: Trk ReceptorsSummary: TrkA inhibitor,potent and selective -
B1864 Valganciclovir HClSummary: prodrug for ganciclovir -
B2092 DoxifluridineSummary: oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU) -
B1602 Donepezil HClTarget: AChESummary: AChE inhibitor -
B1291 Acitretin sodiumSummary: Second-generation, systemic retinoid -
B2204 Enalaprilat DihydrateSummary: angiotensin-converting enzyme (ACE) inhibitor -
B2062 VidarabineSummary: antiviral drug for herpes viruses -
B1147 Orotic acidSummary: Pyrimidinecarboxylic acid -
B2287 LY3649474 CitationSummary: inhibitor of TGF-β type I receptor kinase domain -
B2299 MozavaptanSummary: novel competitive vasopressin receptor antagonist

